查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1679170

商業水產養殖疫苗市場：全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2032）

Commercial Aquaculture Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 366 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球商業水產養殖疫苗市場的綜合報告。該報告對關鍵市場動態進行了全面評估，包括市場促進因素、趨勢、機會、促進因素和挑戰，並對市場結構提供了詳細的見解。本研究報告採用獨家資料和統計數據，概述了 2025 年至 2032 年全球商業水產養殖疫苗市場的預期成長軌跡。

關鍵見解

  • 商業水產養殖疫苗市場規模（2025年）：4.564億美元
  • 預計市場價值（2032年）：7.428億美元
  • 全球市場成長率（2025-2032年複合年成長率）：7.2%

商業水產養殖疫苗市場-報告內容：

商業水產養殖疫苗在養殖水生物種的疾病預防中發揮著至關重要的作用，可確保更高的存活率和更高的生產力。這些疫苗有助於降低細菌、病毒和寄生蟲感染的風險，減少對抗生素的依賴，並提高水產養殖實踐的永續性。該市場為魚類養殖場、孵化場和水產養殖公司提供各種疫苗，包括去活化疫苗、減毒活病毒疫苗、重組疫苗和基於 DNA 的疫苗。市場成長的動力來自水產養殖產量的增加、疾病發生率的上升以及促進永續水產養殖實踐的嚴格法規。

市場成長動力：

全球商業水產養殖疫苗市場受到幾個關鍵因素的推動，包括對水產品的需求增加導致水產養殖活動增加。人們對魚類養殖場疾病爆發及其相關經濟損失的日益擔憂加強了疫苗的採用。全球監管機構正在實施更嚴格的指導方針，以減少水產養殖的抗生素使用，進一步推動對疫苗的需求。 DNA疫苗和重組疫苗等技術進步正在提高疫苗的功效和應用，有助於擴大市場。此外，對水產養殖衛生和生物安全措施的投資增加為疫苗的採用創造了新的機會。

市場限制：

儘管成長前景看好，商業水產養殖疫苗市場仍面臨高昂的開發成本和漫長的監管核准流程等挑戰。不同水環境中疾病管理的複雜性以及魚類免疫反應的多變性也對疫苗的有效性構成了挑戰。特別是在新興市場，小規模水產養殖場的認知和疫苗採用有限，阻礙了市場滲透。此外，與儲存和分發疫苗相關的後勤挑戰（包括低溫運輸要求）增加了營運成本並限制了疫苗的廣泛使用。解決這些障礙需要產業相關人員、政府和研究機構之間的合作，以提高疫苗的可用性和可負擔性。

市場機會：

隨著對更易於管理的新型疫苗製劑（如口服疫苗和浸入式疫苗）的研究不斷增加，商業水產養殖疫苗市場提供了巨大的成長機會。精準農業技術的擴展，例如即時疾病監測和自動疫苗接種系統，預計將提高疫苗的有效性和採用率。亞太和拉丁美洲的新興市場水產養殖業蓬勃發展，為疫苗製造商提供了豐厚的前景。製藥公司、水產養殖公司和政府機構之間的策略聯盟可以加速疫苗的開發和分發。此外，人們對永續水產養殖實踐和環境友善疾病預防解決方案的日益關注為疫苗創新創造了有利的市場環境。

本報告探討的關鍵問題

  • 推動全球商業水產養殖疫苗市場成長的關鍵因素有哪些？
  • 哪些疫苗類型和使用方法正在獲得業界支持？
  • 科技進步如何影響疫苗的開發與管理？
  • 市場的主要企業在哪裡？他們採用什麼策略來獲得競爭優勢？
  • 全球商業水產養殖疫苗市場有哪些新興趨勢與前景？

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 增值洞察

  • 產品採用分析
  • 水產養殖生產概況
  • 主要國家魚貝類消費狀況
  • 水產養殖疾病爆發－概述
  • 不同給藥途徑的比較分析
  • 監管狀況
  • 價值鏈分析
  • 波特五力分析
  • PESTLE分析

4. 全球商業水產養殖疫苗市場展望

  • 主要亮點
    • 市場規模及與前一年同期比較率
    • 絕對的商機
  • 市場規模分析與預測
    • 2019-2024 年歷史市場規模分析
    • 目前市場規模分析與預測，2025-2032
  • 全球商業水產養殖疫苗市場展望：疫苗類型
    • 簡介/主要發現
    • 2019 年至 2024 年疫苗類型市場規模歷史分析
    • 2025-2032 年疫苗市場規模分析及預測
      • 惰性
      • 衰減
      • 次單元
      • DNA
    • 市場吸引力分析：疫苗類型
  • 全球商業水產養殖疫苗市場展望：病原體
    • 簡介/主要發現
    • 2019 年至 2024 年病原體市場規模歷史分析
    • 2025 年至 2032 年病原體市場規模分析與預測
      • 細菌
      • 病毒
    • 市場吸引力分析：病原體
  • 全球商業水產養殖疫苗市場展望：按類型
    • 簡介/主要發現
    • 2019 年至 2024 年按類型分類的歷史市場規模分析
    • 2025 年至 2032 年按類型分類的當前市場規模分析與預測
      • 鮭魚
      • 吳郭魚
      • 鱒魚
      • 海鱸魚
      • 鯉魚
      • 大菱鮃
      • 魴
      • 其他
    • 市場吸引力分析：類型
  • 全球商業水產養殖疫苗市場展望：給藥途徑
    • 簡介/主要發現
    • 2019 年至 2024 年按給藥途徑分類的歷史市場規模分析
    • 2025 年至 2032 年按給藥途徑分類的當前市場規模分析與預測
      • 腹腔內
      • 肌肉注射
      • 浸沒
      • 口服
    • 市場吸引力分析：給藥途徑
  • 全球商業水產養殖疫苗市場展望：最終用戶
    • 簡介/主要發現
    • 2019 年至 2024 年最終用戶市場規模歷史分析
    • 2025 年至 2032 年按最終用戶分類的當前市場規模分析和預測
      • 水產養殖公司
      • 魚類獸醫診所
      • 水生生物研究所
    • 市場吸引力分析：最終用戶

5. 全球商業水產養殖疫苗市場（按地區）展望

  • 主要亮點
  • 2019 年至 2024 年各地區歷史市場規模分析
  • 2025 年至 2032 年各地區目前市場規模分析與預測
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：地區

6. 北美商業水產養殖疫苗市場展望

7. 歐洲商業水產養殖疫苗市場展望

8. 東亞商業水產養殖疫苗市場展望

9. 南亞和大洋洲商業水產養殖疫苗市場展望

10. 拉丁美洲商業水產養殖疫苗市場展望

11.中東和非洲商業水產養殖疫苗市場展望

第12章競爭格局

  • 2025年市場佔有率分析
  • 市場結構
    • 市場競爭加劇圖
    • 競爭儀錶板
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • Zoetis Animal Healthcare
    • Merck &Co. Inc.
    • ICTYO, Virbac
    • Phibro Animal Health Corporation
    • Elanco Animal Health Incorporated
    • HIPRA
    • Nisseiken Co., Ltd.
    • Tecnovax SA
    • AQUAVET SA
    • IDT Biologika

第13章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP32289

Persistence Market Research has recently released a comprehensive report on the worldwide market for commercial aquaculture vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global commercial aquaculture vaccines market from 2025 to 2032.

Key Insights:

  • Commercial Aquaculture Vaccines Market Size (2025E): US$ 456.4 Mn
  • Projected Market Value (2032F):US$ 742.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.2%

Commercial Aquaculture Vaccines Market - Report Scope:

Commercial aquaculture vaccines play a vital role in disease prevention among farmed aquatic species, ensuring higher survival rates and improved productivity. These vaccines help mitigate the risk of bacterial, viral, and parasitic infections, reducing dependence on antibiotics and enhancing sustainability in aquaculture practices. The market caters to fish farms, hatcheries, and aquaculture companies, offering a range of vaccines, including inactivated, live attenuated, recombinant, and DNA-based vaccines. Market growth is driven by increasing aquaculture production, rising disease outbreaks, and stringent regulations promoting sustainable fish farming practices.

Market Growth Drivers:

The global commercial aquaculture vaccines market is propelled by several key factors, including the rising demand for seafood, which has led to an increase in aquaculture activities. Growing concerns about disease outbreaks in fish farms and the subsequent economic losses have intensified the adoption of vaccines. Regulatory bodies worldwide are enforcing stricter guidelines to reduce antibiotic use in aquaculture, further driving vaccine demand. Technological advancements, such as DNA-based and recombinant vaccines, are improving vaccine efficacy and application methods, fostering market expansion. Additionally, increasing investments in aquaculture health management and biosecurity measures are creating new opportunities for vaccine adoption.

Market Restraints:

Despite promising growth prospects, the commercial aquaculture vaccines market faces challenges related to high development costs and the lengthy regulatory approval process. The complexity of disease management in diverse aquatic environments and variations in fish species' immune responses also pose challenges to vaccine effectiveness. Limited awareness and vaccine adoption in small-scale fish farms, particularly in developing regions, hinder market penetration. Furthermore, the logistical challenges associated with vaccine storage and distribution, including cold chain requirements, increase operational costs and restrict widespread availability. Addressing these barriers requires collaborative efforts between industry players, governments, and research institutions to enhance vaccine accessibility and affordability.

Market Opportunities:

The commercial aquaculture vaccines market presents significant growth opportunities driven by increasing research in novel vaccine formulations, including oral and immersion vaccines, which offer ease of administration. The expansion of precision aquaculture technologies, such as real-time disease monitoring and automated vaccination systems, is expected to improve vaccine effectiveness and adoption rates. Emerging markets in Asia-Pacific and Latin America, where aquaculture is rapidly growing, offer lucrative prospects for vaccine manufacturers. Strategic collaborations between pharmaceutical companies, aquaculture firms, and government agencies can accelerate vaccine development and distribution. Additionally, the growing focus on sustainable aquaculture practices and environmentally friendly disease prevention solutions creates a favorable market landscape for vaccine innovation.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the commercial aquaculture vaccines market globally?
  • Which vaccine types and application methods are gaining traction in the industry?
  • How are technological advancements influencing vaccine development and administration?
  • Who are the key players in the market, and what strategies are they employing for competitive advantage?
  • What are the emerging trends and future prospects in the global commercial aquaculture vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global commercial aquaculture vaccines market, including Zoetis Inc., Merck Animal Health, and Elanco Animal Health, focus on R&D investments, strategic partnerships, and product innovations to strengthen their market presence. Companies are developing advanced vaccine solutions, such as recombinant and DNA-based vaccines, to enhance efficacy and reduce side effects. Collaborations with aquaculture farms, research institutions, and government agencies are facilitating knowledge exchange and technology adoption. Moreover, expanding manufacturing capabilities, optimizing supply chain logistics, and investing in educational initiatives for fish farmers contribute to market growth and sustainability.

Key Companies Profiled:

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • HIPRA
  • Virbac
  • Phibro Animal Health Corporation
  • Tecnovax
  • Vaxxinova
  • Benchmark Holdings PLC
  • KBNP Inc.

Commercial Aquaculture Vaccines Market Scope

By Vaccine:

  • Inactivated
  • Attenuated
  • Subunit
  • DNA

By Pathogen:

  • Bacteria
  • Virus

By Species:

  • Salmon
  • Tilapia
  • Trout
  • Sea Bass
  • Carp
  • Turbot
  • Bream

By Route of Administration:

  • Intraperitoneal
  • Intramuscular
  • Immersion
  • Oral

By End User:

  • Fish Farming Companies
  • Fish Veterinary Clinics
  • Aquatic Research Institutes

Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Commercial Aquaculture Vaccines Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Aquaculture Fisheries Production Overview
  • 3.3. Fish and Seafood Consumption Scenario, by Key Country
  • 3.4. Aquaculture Disease Outbreaks - Overview
  • 3.5. Comparative Analysis for Various Route of Administration
  • 3.6. Regulatory Landscape
  • 3.7. Value Chain Analysis
  • 3.8. Porter's Five Force Analysis
  • 3.9. PESTLE Analysis

4. Global Commercial Aquaculture Vaccines Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Commercial Aquaculture Vaccines Market Outlook: Vaccine Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Vaccine Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
      • 4.3.3.1. Inactivated
      • 4.3.3.2. Attenuated
      • 4.3.3.3. Subunit
      • 4.3.3.4. DNA
    • 4.3.4. Market Attractiveness Analysis: Vaccine Type
  • 4.4. Global Commercial Aquaculture Vaccines Market Outlook: Pathogen
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Pathogen, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
      • 4.4.3.1. Bacteria
      • 4.4.3.2. Virus
    • 4.4.4. Market Attractiveness Analysis: Pathogen
  • 4.5. Global Commercial Aquaculture Vaccines Market Outlook: Species
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Species, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
      • 4.5.3.1. Salmon
      • 4.5.3.2. Tilapia
      • 4.5.3.3. Trout
      • 4.5.3.4. Sea Bass
      • 4.5.3.5. Carp
      • 4.5.3.6. Turbot
      • 4.5.3.7. Bream
      • 4.5.3.8. Others
    • 4.5.4. Market Attractiveness Analysis: Species
  • 4.6. Global Commercial Aquaculture Vaccines Market Outlook: Route of Administration
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019-2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      • 4.6.3.1. Intraperitoneal
      • 4.6.3.2. Intramuscular
      • 4.6.3.3. Immersion
      • 4.6.3.4. Oral
    • 4.6.4. Market Attractiveness Analysis: Route of Administration
  • 4.7. Global Commercial Aquaculture Vaccines Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.7.3.1. Fish Farming Companies
      • 4.7.3.2. Fish Veterinary Clinics
      • 4.7.3.3. Aquatic Research Institutes
    • 4.7.4. Market Attractiveness Analysis: End User

5. Global Commercial Aquaculture Vaccines Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Commercial Aquaculture Vaccines Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Vaccine Type
    • 6.2.3. By Pathogen
    • 6.2.4. By Species
    • 6.2.5. By Route of Administration
    • 6.2.6. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 6.4.1. Inactivated
    • 6.4.2. Attenuated
    • 6.4.3. Subunit
    • 6.4.4. DNA
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 6.5.1. Bacteria
    • 6.5.2. Virus
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 6.6.1. Salmon
    • 6.6.2. Tilapia
    • 6.6.3. Trout
    • 6.6.4. Sea Bass
    • 6.6.5. Carp
    • 6.6.6. Turbot
    • 6.6.7. Bream
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 6.7.1. Intraperitoneal
    • 6.7.2. Intramuscular
    • 6.7.3. Immersion
    • 6.7.4. Oral
  • 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.8.1. Fish Farming Companies
    • 6.8.2. Fish Veterinary Clinics
    • 6.8.3. Aquatic Research Institutes
  • 6.9. Market Attractiveness Analysis

7. Europe Commercial Aquaculture Vaccines Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Vaccine Type
    • 7.2.3. By Pathogen
    • 7.2.4. By Species
    • 7.2.5. By Route of Administration
    • 7.2.6. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Norway
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. U.K.
    • 7.3.5. Italy
    • 7.3.6. Spain
    • 7.3.7. Russia
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 7.4.1. Inactivated
    • 7.4.2. Attenuated
    • 7.4.3. Subunit
    • 7.4.4. DNA
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 7.5.1. Bacteria
    • 7.5.2. Virus
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 7.6.1. Salmon
    • 7.6.2. Tilapia
    • 7.6.3. Trout
    • 7.6.4. Sea Bass
    • 7.6.5. Carp
    • 7.6.6. Turbot
    • 7.6.7. Bream
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 7.7.1. Intraperitoneal
    • 7.7.2. Intramuscular
    • 7.7.3. Immersion
    • 7.7.4. Oral
  • 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Fish Farming Companies
    • 7.8.2. Fish Veterinary Clinics
    • 7.8.3. Aquatic Research Institutes
  • 7.9. Market Attractiveness Analysis

8. East Asia Commercial Aquaculture Vaccines Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Vaccine Type
    • 8.2.3. By Pathogen
    • 8.2.4. By Species
    • 8.2.5. By Route of Administration
    • 8.2.6. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 8.4.1. Inactivated
    • 8.4.2. Attenuated
    • 8.4.3. Subunit
    • 8.4.4. DNA
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 8.5.1. Bacteria
    • 8.5.2. Virus
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 8.6.1. Salmon
    • 8.6.2. Tilapia
    • 8.6.3. Trout
    • 8.6.4. Sea Bass
    • 8.6.5. Carp
    • 8.6.6. Turbot
    • 8.6.7. Bream
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 8.7.1. Intraperitoneal
    • 8.7.2. Intramuscular
    • 8.7.3. Immersion
    • 8.7.4. Oral
  • 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Fish Farming Companies
    • 8.8.2. Fish Veterinary Clinics
    • 8.8.3. Aquatic Research Institutes
  • 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Commercial Aquaculture Vaccines Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Vaccine Type
    • 9.2.3. By Pathogen
    • 9.2.4. By Species
    • 9.2.5. By Route of Administration
    • 9.2.6. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 9.4.1. Inactivated
    • 9.4.2. Attenuated
    • 9.4.3. Subunit
    • 9.4.4. DNA
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 9.5.1. Bacteria
    • 9.5.2. Virus
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 9.6.1. Salmon
    • 9.6.2. Tilapia
    • 9.6.3. Trout
    • 9.6.4. Sea Bass
    • 9.6.5. Carp
    • 9.6.6. Turbot
    • 9.6.7. Bream
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 9.7.1. Intraperitoneal
    • 9.7.2. Intramuscular
    • 9.7.3. Immersion
    • 9.7.4. Oral
  • 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Fish Farming Companies
    • 9.8.2. Fish Veterinary Clinics
    • 9.8.3. Aquatic Research Institutes
  • 9.9. Market Attractiveness Analysis

10. Latin America Commercial Aquaculture Vaccines Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Vaccine Type
    • 10.2.3. By Pathogen
    • 10.2.4. By Species
    • 10.2.5. By Route of Administration
    • 10.2.6. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 10.4.1. Inactivated
    • 10.4.2. Attenuated
    • 10.4.3. Subunit
    • 10.4.4. DNA
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 10.5.1. Bacteria
    • 10.5.2. Virus
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 10.6.1. Salmon
    • 10.6.2. Tilapia
    • 10.6.3. Trout
    • 10.6.4. Sea Bass
    • 10.6.5. Carp
    • 10.6.6. Turbot
    • 10.6.7. Bream
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 10.7.1. Intraperitoneal
    • 10.7.2. Intramuscular
    • 10.7.3. Immersion
    • 10.7.4. Oral
  • 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Fish Farming Companies
    • 10.8.2. Fish Veterinary Clinics
    • 10.8.3. Aquatic Research Institutes
  • 10.9. Market Attractiveness Analysis

11. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Vaccine Type
    • 11.2.3. By Pathogen
    • 11.2.4. By Species
    • 11.2.5. By Route of Administration
    • 11.2.6. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. South Africa
    • 11.3.3. Northern Africa
    • 11.3.4. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 11.4.1. Inactivated
    • 11.4.2. Attenuated
    • 11.4.3. Subunit
    • 11.4.4. DNA
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 11.5.1. Bacteria
    • 11.5.2. Virus
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 11.6.1. Salmon
    • 11.6.2. Tilapia
    • 11.6.3. Trout
    • 11.6.4. Sea Bass
    • 11.6.5. Carp
    • 11.6.6. Turbot
    • 11.6.7. Bream
    • 11.6.8. Others
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 11.7.1. Intraperitoneal
    • 11.7.2. Intramuscular
    • 11.7.3. Immersion
    • 11.7.4. Oral
  • 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Fish Farming Companies
    • 11.8.2. Fish Veterinary Clinics
    • 11.8.3. Aquatic Research Institutes
  • 11.9. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Zoetis Animal Healthcare
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Merck & Co. Inc.
    • 12.3.3. ICTYO, Virbac
    • 12.3.4. Phibro Animal Health Corporation
    • 12.3.5. Elanco Animal Health Incorporated
    • 12.3.6. HIPRA
    • 12.3.7. Nisseiken Co., Ltd.
    • 12.3.8. Tecnovax S.A.
    • 12.3.9. AQUAVET S.A.
    • 12.3.10. IDT Biologika

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations